The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias

OBJECTIVE: Although lung squamous cell carcinoma (SCC) accounts for 20-30% of lung cancer cases, new treatment options are limited. The CA031 study showed that nanoparticle albumin-bound-paclitaxel (nab-PTX) plus carboplatin produced a significantly higher overall response rate (41%) than solvent-ba...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Intern Med
Autori principali: Fujita, Tetsuo, Hiroishi, Takuma, Shikano, Kohei, Yanagisawa, Asako, Hayama, Noriko, Amano, Hiroyuki, Nakamura, Makoto, Hirano, Satoshi, Tabeta, Hiroshi, Nakamura, Sukeyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Japanese Society of Internal Medicine 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064686/
https://ncbi.nlm.nih.gov/pubmed/29434143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0404-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi